Business Context and Reporting Period
Company: AMBEV S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Fourth Quarter and Full Year ended December 31, 2020
Reporting Date: February 25, 2021
Accounting Standards: IFRS (International Financial Reporting Standards)
Ambev reported results for 2020, a year marked by the COVID-19 pandemic. The company maintained operational continuity across all breweries and distribution centers. Results were significantly impacted by a one-time recognition of R$4.3 billion in tax credits in Brazil related to litigation over the ICMS state tax.
Key Financial Metrics
| Metric (R$ Million) | 4Q20 | 4Q19 | YTD 2020 | YTD 2019 |
|---|---|---|---|---|
| Net Revenue | 18,556.6 | 15,474.7 | 58,379.0 | 52,005.1 |
| Volume ('000 hl) | 50,942.0 | 47,295.7 | 165,797.9 | 163,243.0 |
| Normalized EBITDA | 8,937.2 | 6,924.7 | 21,591.5 | 21,147.1 |
| Normalized Profit | 7,008.0 | 4,633.5 | 12,104.3 | 12,549.9 |
| Normalized EPS (R$) | 0.44 | 0.29 | 0.75 | 0.77 |
| Cash Flow from Operating Activities | 8,393.6 | 9,634.9 | 18,855.8 | 18,381.3 |
| CAPEX | 1,394.4 | 2,003.9 | 4,692.7 | 5,069.4 |
| Net Debt/(Cash) | (13,998.1) | (8,852.4) | (13,998.1) | (8,852.4) |
Note: Net Debt is negative, indicating a net cash position.
Material Changes vs. Prior Period
- Revenue Growth: Consolidated net revenue increased 13.4% organically in 4Q20 and 4.7% for the full year. Volume grew 7.6% in 4Q20 and 1.4% for the full year.
- Regional Performance: Brazil (+19.0% revenue), Latin America South (LAS) (+16.3%), and Central America/Caribbean (CAC) (+0.2%) drove growth. Canada declined (-4.7%) due to industry-wide restrictions.
- Margin Compression: Gross margin decreased 280 bps to 55.8% in 4Q20 and 480 bps to 53.6% for the full year. EBITDA margin decreased 500 bps to 48.2% in 4Q20 and 590 bps to 37.0% for the full year.
- Drivers: Increases in Cost of Goods Sold (COGS) were driven by inflationary pressures in Argentina, currency headwinds, and packaging mix impacts. SG&A expenses increased to support top-line recovery.
- Profitability: Normalized profit increased 51.2% in 4Q20 but decreased 3.6% for the full year. The Q4 surge was heavily influenced by the recognition of R$4.3 billion in tax credits.
- Organic EBITDA: Organic Normalized EBITDA decreased 0.1% in 4Q20 and 11.1% for the full year, excluding the impact of tax credits.
- Liquidity: Cash and cash equivalents increased to R$17.09 billion (from R$11.90 billion in 2019). The company maintained a net cash position of R$13.99 billion.
Guidance, Outlook, and Risks
- 2021 Outlook: Management expects top-line recovery to outpace bottom-line recovery. Significant transactional FX and commodity headwinds are anticipated to pressure EBITDA margins.
- Cost Expectations: Cash COGS per hectoliter in Brazil Beer is expected to increase in the low-twenties due to FX and commodity costs.
- Volume: Brazil beer volume growth started 2021 above 10%.
- Key Risks:
- Pandemic Uncertainty: The scale and magnitude of COVID-19 impacts remain fluid, affecting consumption occasions and restrictions.
- Hyperinflation: Argentina is classified as a hyperinflationary economy (IAS 29), requiring restatement of results which impacts reported figures.
- FX Volatility: Significant exposure to currency fluctuations, particularly BRL/USD and ARS/BRL.
- Unusual Items:
- Tax Credits: R$4.3 billion recognized in Q4 2020 related to Brazilian Supreme Court decisions on ICMS/PIS/COFINS. This is considered a non-recurring item for organic performance analysis.
- Exceptional Items: R$140.2 million in Q4 2020 (R$452.0 million YTD) related to COVID-19 costs, restructuring, and state amnesty.
Investor Verification Checklist
- Tax Credit Sustainability: Verify the legal finality of the R$4.3 billion tax credit and its impact on future cash flows versus one-time accounting recognition.
- Argentina Hyperinflation: Review the specific impact of IAS 29 restatements on LAS segment margins and EBITDA, as these distortions are significant.
- Organic vs. Reported Growth: Distinguish between reported growth (inflated by tax credits) and organic growth (which showed EBITDA decline) to assess underlying operational health.
- Cost Inflation: Monitor the realization of the "low-twenties" COGS increase forecast for 2021 and its ability to be offset by volume and price mix.
- Net Cash Position: Confirm the stability of the R$13.99 billion net cash position given the high dividend payout history and potential for increased CAPEX in 2021.